Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 38: 132-140, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fairbanks, V. F.
Right arrow Articles by O'Brien, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairbanks, V. F.
Right arrow Articles by O'Brien, P. C.

Clinical Chemistry, Vol 38, 132-140, Copyright © 1992 by American Association for Clinical Chemistry

Methods for measuring plasma hemoglobin in micromolar concentration compared

VF Fairbanks, SC Ziesmer and PC O'Brien
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.

Of eight methods examined for measuring plasma hemoglobin in micromolar concentration, all exhibited acceptable linearity, reproducibility, and concurrence except when specimens were icteric or lipemic or contained methemoglobin or methemalbumin. Measurement of absorbance at 578 nm with an Allen correction permits precise assay of plasma oxyhemoglobin concentration as low as 0.01 g/L (1 mg/dL, 0.16 mumol/L), unaffected by hyperlipidemia or hyperbilirubinemia. Discrepancies between methods occurred in 11.6% of a consecutive series of 50 nonicteric patients' plasma specimens. Examination of absorption spectra is helpful when discrepancies are observed between methods. The presence of methemalbumin or methemoglobin in plasma is not recognized by methods that measure only oxyhemoglobin. Increased ceruloplasmin or beta- carotene does not significantly affect results.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J. Unger, G. Filippi, and W. Patsch
Measurements of Free Hemoglobin and Hemolysis Index: EDTA- or Lithium-Heparinate Plasma?
Clin. Chem., September 1, 2007; 53(9): 1717 - 1718.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Hernandez, E. Carrasco, R. Casamitjana, R. Deulofeu, J. Garcia-Arumi, and R. Simo
Somatostatin Molecular Variants in the Vitreous Fluid: A comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects
Diabetes Care, August 1, 2005; 28(8): 1941 - 1947.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. Canton, E. M. Martinez-Caceres, C. Hernandez, C. Espejo, J. Garcia-Arumi, and R. Simo
CD4-CD8 and CD28 Expression in T Cells Infiltrating the Vitreous Fluid in Patients With Proliferative Diabetic Retinopathy: A Flow Cytometric Analysis
Arch Ophthalmol, May 1, 2004; 122(5): 743 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Simo, A. Lecube, L. Sararols, J. Garcia-Arumi, R. M. Segura, R. Casamitjana, and C. Hernandez
Deficit of Somatostatin-Like Immunoreactivity in the Vitreous Fluid of Diabetic Patients: Possible role in the development of proliferative diabetic retinopathy
Diabetes Care, December 1, 2002; 25(12): 2282 - 2286.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. Gburek, P. J. Verroust, T. E. Willnow, J. C. Fyfe, W. Nowacki, C. Jacobsen, S. K. Moestrup, and E. I. Christensen
Megalin and Cubilin are Endocytic Receptors Involved in Renal Clearance of Hemoglobin
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 423 - 430.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. S. Holt, M. Botto, A. E. Bygrave, S. M. Hanna, M. J. Walport, and B. P. Morgan
Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria
Blood, July 15, 2001; 98(2): 442 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Almagor and O. Lavid-Levy
Effects of Blood-Collection Systems and Tubes on Hematologic, Chemical, and Coagulation Tests and on Plasma Hemoglobin
Clin. Chem., April 1, 2001; 47(4): 794 - 795.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Hernández, R. Burgos, A. Cantón, J. García-Arumí, R. M. Segura, and R. Simó
Vitreous Levels of Vascular Cell Adhesion Molecule and Vascular Endothelial Growth Factor in Patients With Proliferative Diabetic Retinopathy: A case-control study
Diabetes Care, March 1, 2001; 24(3): 516 - 521.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J. K Jackson and D. P Derleth
Effects of various arterial infusion solutions on red blood cells in the newborn
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 130F - 134.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.